Pregnancy Could Help Reduce the Risk of Long COVID
Drug Topics
APRIL 2, 2025
A study found that patients who acquired a SARS-CoV-2 infection during pregnancy had a lower risk of developing long COVID compared to those who were not pregnant.
Drug Topics
APRIL 2, 2025
A study found that patients who acquired a SARS-CoV-2 infection during pregnancy had a lower risk of developing long COVID compared to those who were not pregnant.
STAT
APRIL 1, 2025
Layoff notices began arriving early Tuesday for thousands of employees of the sprawling Department of Health and Human Services and its subsidiary agencies, with as many 10,000 workers potentially expected to be hit by the cuts. “I regret to inform you that you have been affected by a reduction in force (RIF) action,” an email to affected employees said.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PharmaVoice
APRIL 2, 2025
Amid widespread staff reductions at health agencies, a number of key officials have bid farewell to pharma’s top regulator.
European Pharmaceutical Review
APRIL 4, 2025
New findings from The Pistoia Alliance report major challenges to adoption of data-driven innovation and AI in life sciences. The research is based on a poll conducted at the organisations annual European conference. Resistance to change emerged as the biggest obstacle to innovation (51 percent). To overcome this, the Alliance urged the pharmaceutical industry to prioritise cultural and behavioural change in digital transformation efforts.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharma Marketing Network
APRIL 2, 2025
Introduction If the past few years have taught pharma marketers anything, it’s that agility, data, and digital-first thinking aren’t just buzzwordsthey’re survival tactics. Marketing in pharma has undergone a radical shift, propelled by digital transformation, patient-centric demands, and evolving regulatory landscapes. In 2025, the strategies that succeed are rooted in personalization, innovation, and real-time adaptability.
Drug Topics
APRIL 3, 2025
Bird flu cases total 70 US patients as more animals are infected.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
PharmaVoice
MARCH 31, 2025
The two market leaders are targeting new obesity alternatives in their pipelines with an eye toward a triple threat.
The FDA Law Blog
APRIL 1, 2025
By Dr. Naomi Lowy, Principal Drug Regulatory Expert Trade and national press have reported that recent changes in FDA staffing levels have already led to slower responses to calls and emails. According to reports, which were published before the most recent reports of HHS staff level reductions and tumultuous changes in leadership, FDA staff were missing minor deadlines.
Pharmacy Times
MARCH 31, 2025
A phase 1/2 clinical trial will provide crucial data on the vaccine's tolerability and pave the way for future development and potential widespread use.
Drug Topics
MARCH 31, 2025
Jean-Venable Goode, BSPharm, PharmD, and Jeff Goad, PharmD, MPH, presented on the most notable vaccine updates from the past year and how they impact pharmacy practice.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
APRIL 4, 2025
After Hurricane Ian, as Floridians returned home to sodden furniture and moldy piles of debris, many with asthma could feel their chests tightening. To figure out what was safe, some sent their concerns directly to the U.S. Centers for Disease Control and Prevention. But on Tuesday — days before floods ravaged Nashville, potentially prompting similar queries — the people who would normally answer such asthma questions stopped working.
PharmaVoice
APRIL 1, 2025
The lack of clear communication from the government could spark wide-ranging issues in pharma — from sowing confusion about clinical trial design to further eroding public trust.
Hospital Pharmacy Europe
MARCH 31, 2025
Sustainability has become central to the mission of hospital pharmacists, who are uniquely positioned to minimise waste, reduce healthcares environmental footprint and enhance patient outcomes. In his latest commentary, Dr Joo Gonalves PhD explores how digital health tools, artificial intelligence and circular economy models can drive meaningful change in hospital pharmacy practice.
The Checkup by Singlecare
APRIL 4, 2025
Venlafaxine , commonly known by the brand name Effexor or Effexor XR, is a prescription drug used to manage symptoms of depression and other mood disorders. After being prescribed venlafaxine, you might wonder about your lifestyle choices while on this drug. A common question arises when people get invited to a social gathering or celebrationcan you enjoy a drink while taking venlafaxine?
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Drug Topics
APRIL 1, 2025
Black women and those living in Southern states had the highest rates of maternal mortality.
STAT
MARCH 31, 2025
Dana, a 29-year-old nurse in St. Louis, checks her phone to see if the gig nursing app CareRev still has her scheduled at the local hospital. She’s already arranged child care for her son, but cancellations are common. “It’s a gamble. … I’ll wake up at 5 in the morning, and I’ll find out if I’m canceled or not,” she told us.
PharmaVoice
APRIL 4, 2025
Isomorphic Labs recently raked in $600 million to help develop its drug discovery platform.
The Happy PharmD
MARCH 30, 2025
If you think your patients arent looking at online pharmacies for cheaper medications, youre kidding yourself. Medicine is expensiveeverything is expensive. And when people are desperate, they look for alternatives. The problem? 96% of online pharmacies are illegal. Theyre selling unregulated, potentially dangerous medications, and most patients have no idea.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharmafile
APRIL 4, 2025
A new progesterone-based treatment aimed at preventing miscarriage has been launched across the UK, following a major clinical trial that demonstrated a significant improvement in live birth rates. Prometrium, a 400mg soft vaginal capsule developed by Besins Healthcare, is now available in England, Wales, Scotland and Northern Ireland. It is designed for use by women […] The post New hormonal treatment launched to help prevent miscarriage in early pregnancy appeared first on Pharmafile.
Drug Topics
APRIL 3, 2025
As over-the-counter birth control becomes increasingly available, pharmacists are uniquely positioned to bridge critical gaps in reproductive health care.
STAT
APRIL 1, 2025
The CDC cuts announced Tuesday threaten America’s health, safety, and economy. Despite claims of efficiency, these cuts target proven programs that prevent disease and save lives — and as a result, Americans will be sicker and face increased health care costs. The government’s goal should not be to hit an arbitrary number of jobs eliminated, but to focus on the number of illnesses and premature deaths prevented.
PharmaVoice
APRIL 1, 2025
Dr. Mikael Dolsten, Pfizer’s former chief scientific officer, is embarking on a journey of curiosity and interconnectedness in his post-Big Pharma career.
Pharmacy Times
MARCH 30, 2025
The trial is the first to test the cardiovascular benefits of an oral glucagon-like peptide-1 (GLP-1) agonist.
Pharma Marketing Network
APRIL 4, 2025
In the world of pharma marketing, the strategies that truly resonate are often those rooted in trust. Thats why referral marketing is gaining traction among pharmaceutical brands looking to increase engagement with both healthcare professionals and patients. Rather than relying solely on paid ads or direct promotion, referral marketing uses personal recommendations to generate awareness, interest, and ultimately, conversions.
Drug Topics
APRIL 2, 2025
All 3 types of virtual diabetes self-management interventions lead to better results in hemoglobin A1c over a 6-month period.
STAT
MARCH 31, 2025
Heart disease has long been the leading killer of adults, but beyond that stark fact, men and women diverge. From differences at the cellular level of the heart to circulatory structure to symptoms of distress and treatment, researchers are finding new manifestations of gender differences in cardiovascular disease.
The Checkup by Singlecare
APRIL 3, 2025
Telemedicine is defined as the remote delivery of healthcare services using a phone, tablet, or computer, according to the Centers for Disease Control and Prevention. Starting with the COVID-19 pandemic, telemedicine expanded rapidly and redefined the delivery of medical services in virtually every aspect of healthcare. Pharmacy is no exception. Telepharmacy utilizes technology to deliver pharmacy services in an innovative way, according to an article published in Integrated Pharmacy Research an
European Pharmaceutical Review
APRIL 4, 2025
Analytical testing is an essential part of guaranteeing the quality, safety and effectiveness of pharmaceutical products. However, the process is not without its challenges and it requires a proactive approach if both compliance and efficiency are to be maintained. This is why it is essential to develop and validate analytical methods to support activities and functions such as process validation controls, stability tests and dissolution profiles.
Pharmafile
MARCH 31, 2025
The US Food and Drug Administration (FDA) has approved Qfitlia (fitusiran) as the first therapy in the US to treat haemophilia A or B, with or without inhibitors. The approval of the antithrombin-lowering (AT) drug was based on data from the ATLAS phase 3 studies that Sanofi conducted. Sanofi is an international pharma and healthcare […] The post Qfitlia approved by FDA to treat haemophilia A or B appeared first on Pharmafile.
Drug Topics
APRIL 1, 2025
Community pharmacies have a clear role in public health, as they manage ongoing services and take on a more significant role as immunizers.
STAT
MARCH 31, 2025
The forced resignation of Peter Marks , the Food and Drug Administration official in charge of regulating vaccines, gene therapies, and the blood supply, led to panic over the weekend in the worlds of public health and biopharmaceuticals — two worlds that often agree on very little aside from their belief in the safety and effectiveness of vaccines.
The Checkup by Singlecare
APRIL 1, 2025
Olanzapine (brand names Zyprexa or Zyprexa Zydis) is a second-generation antipsychotic medication that’s FDA approved to treat mental health conditions like schizophrenia and bipolar disorder, including mixed or manic episodes. It’s also approved for treatment-resistant depression or depression with bipolar I disorder in combination with fluoxetine.
Hospital Pharmacy Europe
APRIL 1, 2025
A new toolkit to support pharmacists when integrating artificial intelligence (AI) into daily practice has been launched by the International Pharmaceutical Federation (FIP). The toolkit for hospital, industry and community settings offers structured guidance on AI adoption. It covers ethical considerations, implementation strategies, regulatory compliance and real-world applications to help pharmacists optimise patient care, stimulate multidisciplinary interaction and enhance operational effici
Let's personalize your content